fulvestrant has been researched along with tubacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funata, N; Hayashi, S; Hirose, M; Horiguchi, S; Itoh, A; Kawakami, M; Saji, S; Schreiber, SL; Toi, M; Yoshida, M; Yoshida, N | 1 |
| Cai, X; Chai, R; Chen, J; Chen, L; Gong, X; Gu, J; Liu, Y; Mo, L; Thiery, JP; Wang, X; Wu, C; Wu, X; Yu, S; Yu, Z; Zhang, J; Zhu, T | 1 |
2 other study(ies) available for fulvestrant and tubacin
| Article | Year |
|---|---|
Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.
Topics: Anilides; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Multivariate Analysis; Prognosis; Selective Estrogen Receptor Modulators; Tamoxifen; Tubulin | 2005 |
Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast Cancer.
Topics: Acetylation; Anilides; Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Cycle; Cell Line, Tumor; Cell Survival; Estradiol; Female; Fulvestrant; Histone Deacetylase 6; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Immunohistochemistry; Lactams, Macrocyclic; Mice; Tamoxifen; Triple Negative Breast Neoplasms | 2017 |